| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1050394691 |
| P356 | DOI | 10.2165/00003088-200847020-00003 |
| P698 | PubMed publication ID | 18193916 |
| P2093 | author name string | Lu Zhang | |
| Richard Lucas | |||
| Evelyn D Lobo | |||
| Mary Pat Knadler | |||
| Tonya Quinlan | |||
| Corina Loghin | |||
| Jill Chappell | |||
| Richard F Bergstrom | |||
| P2860 | cites work | Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication | Q22253031 |
| Citalopram and breast-feeding: serum concentration and side effects in the infant | Q28369848 | ||
| Antidepressants and breast-feeding: a review of the literature | Q33999207 | ||
| The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations | Q34177876 | ||
| Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants | Q34323631 | ||
| A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain | Q34464747 | ||
| Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk. | Q35802378 | ||
| Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants | Q35804367 | ||
| The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects | Q36005626 | ||
| Anxiety disorders during pregnancy and the postpartum period: A systematic review. | Q36590652 | ||
| Use of sertraline, paroxetine and fluvoxamine by nursing women | Q43694345 | ||
| Venlafaxine and breast-feeding | Q43812710 | ||
| Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers | Q44351158 | ||
| Studies in human lactation: milk composition and daily secretion rates of macronutrients in the first year of lactation | Q44512884 | ||
| Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects | Q44550584 | ||
| Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence | Q44763401 | ||
| Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome p450 genotypes. | Q45058753 | ||
| Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial | Q45181161 | ||
| Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial | Q48476503 | ||
| A retrospective pooled analysis of duloxetine safety in 23,983 subjects | Q48479137 | ||
| Pharmacokinetics and safety of duloxetine, a dual-serotonin and norepinephrine reuptake inhibitor | Q48732420 | ||
| Serial assessment of the cardiovascular system in normal pregnancy. Role of arterial compliance and pulsatile arterial load. | Q52264316 | ||
| Urinary incontinence across the lifespan | Q57338659 | ||
| The effects of birth on urinary continence mechanisms and other pelvic-floor characteristics | Q77385671 | ||
| P433 | issue | 2 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| postpartum period | Q749115 | ||
| P304 | page(s) | 103-109 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Clinical Pharmacokinetics | Q5133788 |
| P1476 | title | Pharmacokinetics of duloxetine in breast milk and plasma of healthy postpartum women | |
| P478 | volume | 47 |
| Q37872294 | Adverse reactions to duloxetine in depression |
| Q37801369 | Antidepressant Drugs and Breastfeeding: A Review of the Literature |
| Q24611422 | Antidepressant medication use during breastfeeding |
| Q90394769 | Application of an Inter-Species Extrapolation Method for the Prediction of Drug Interactions between Propolis and Duloxetine in Humans |
| Q37870757 | Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation |
| Q34663934 | Duloxetine for the treatment of fibromyalgia |
| Q48901602 | Duloxetine transfer across the placenta during pregnancy and into milk during lactation |
| Q38067355 | Duloxetine: a review of its use in the management of major depressive disorder in older adults |
| Q34983801 | Duloxetine: a review of its use in the treatment of generalized anxiety disorder |
| Q37848815 | Duloxetine: clinical pharmacokinetics and drug interactions |
| Q37523865 | Duloxetine: in patients with fibromyalgia |
| Q85225431 | Estimation of desvenlafaxine transfer into milk and infant exposure during its use in lactating women with postnatal depression |
| Q45949600 | Infant health and neurodevelopmental outcomes following prenatal exposure to duloxetine. |
| Q27027293 | Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring |
| Q34089992 | Pharmacotherapy of postpartum depression |
| Q46040848 | Population pharmacokinetics of orally administered duloxetine in patients: implications for dosing recommendation |
| Q38311822 | Serotonin reuptake inhibitors and breastfeeding: a systematic review |
| Q34610187 | Use of common migraine treatments in breast-feeding women: a summary of recommendations |
| Q43266150 | Use of duloxetine in pregnancy and lactation |
Search more.